Skin Pigmentation Types, Causes and Treatment-A Review.
Thawabteh AM, Jibreen A, Karaman D, Thawabteh A, Karaman R.
Molecules. 2023 Jun 18;28(12):4839. doi: 10.3390/molecules28124839.
Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies.
Shenoy A, Madan R.
J Drugs Dermatol. 2020 Aug 1;19(8):763-768. doi: 10.36849/JDD.2020.4887.
Review of the Adverse Effects Associated with Dermal Filler Treatments: Part I Nodules, Granuloma, and Migration.
Hong GW, Hu H, Chang K, Park Y, Lee KWA, Chan LKW, Yi KH.
Diagnostics (Basel). 2024 Jul 30;14(15):1640. doi: 10.3390/diagnostics14151640.
Vitiligo.
Le Poole C, Boissy RE.
Semin Cutan Med Surg. 1997 Mar;16(1):3-14. doi: 10.1016/s1085-5629(97)80030-2.
Photoaging.
Grunebaum LD, Heffelfinger RN.
Curr Probl Dermatol. 2011;42:122-130. doi: 10.1159/000328382. Epub 2011 Aug 16.
APC-Associated Polyposis Conditions.
Yen T, Stanich PP, Axell L, Patel SG.
1998 Dec 18 [updated 2022 May 12]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Pigmentary diseases.
Kim NY, Pandya AG.
Med Clin North Am. 1998 Sep;82(5):1185-207. doi: 10.1016/s0025-7125(05)70410-7.
Disorders of pigmentation.
Fistarol SK, Itin PH.
J Dtsch Dermatol Ges. 2010 Mar;8(3):187-201; quiz 201-2. doi: 10.1111/j.1610-0387.2009.07137.x. Epub 2009 Sep 24.
[Hyperandrogenism in women].
Peigné M, Villers-Capelle A, Robin G, Dewailly D.
Presse Med. 2013 Nov;42(11):1487-99. doi: 10.1016/j.lpm.2013.07.016. Epub 2013 Nov 1.
Facial skin rejuvenation.
Holck DE, Ng JD.
Curr Opin Ophthalmol. 2003 Oct;14(5):246-52. doi: 10.1097/00055735-200310000-00004.
